Meanwhile, YTHDF1 overexpression also significantly augmented the lung metastatic capacity of breast cancer cells (Fig. 6K and Supplementary Fig. S6H), indicated by the increasing number of metastatic nodules in the YTHDF1 OV-treated group. Here, YTHDF1 is linked to breast cancer.